Indocyanine green (ICG) is a water-soluble anionic tricarbocyanine dye developed during the Second World
War that was first approved for clinical use in humans in 1956. The main features of ICG that make it suitable for bioimaging
applications are its near infrared absorption and its fluorescence. Although ICG is mainly used for its fluorescence
emission properties, it has also been hypothesized that it can serve as a photosensitizer for photodynamic therapy
applications, eliciting cytotoxic effects both in vitro and in vivo when used in combination with light at wavelengths in the
region of 800-830 nm. Moreover, ICG can be used for hyperthermia of enhanced-photocoagulation of blood vessels
treatment. In this paper we have gathered all the available data concerning the use of ICG for different treatments.
Keywords: Cytotoxic effects, fluorescence, hyperthermia, indocyanine Green (ICG), photodynamic therapy (PDT), selective
photocoagulation, site-specific therapy.
Rights & PermissionsPrintExport